BMS Extends Choice Line For Diabetics With Foot Care, Oral Care Items
This article was originally published in The Tan Sheet
Executive Summary
Bristol-Myers Squibb plans to extend its Choice DM line of products for people with diabetes to include foot care and oral care items, as well as nutritional bars and shakes, the firm announced at the National Association of Chain Drug Stores Marketplace in San Diego June 8-10
You may also be interested in...
Hi-Tech Diabetic Products To Play Key Role In Firm’s Growth Strategy
Hi-Tech Pharmacal plans to build up its Health Care Products Division through a two-pronged approach involving launching new products aimed at diabetics and expanding distribution channels
Excedrin Quick Tabs Will Be On OTC Shelves By Labor Day
Bristol-Myers Squibb will back the upcoming launch of Excedrin Quick Tabs with a six-month, $20 mil. advertising/marketing campaign, the firm said at the National Association of Chain Drug Stores Marketplace Conference in San Diego, Calif. June 15-18
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC